Porencephaly in an Italian neonate with foetal alcohol spectrum disorder: A case report.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
31 Jul 2020
31 Jul 2020
Historique:
entrez:
7
8
2020
pubmed:
7
8
2020
medline:
25
8
2020
Statut:
ppublish
Résumé
Foetal alcohol spectrum disorder (FASD) is a complex malformative disease caused by the teratogenic effect of alcohol consumed during pregnancy. Mothers are frequently reluctant to admit alcohol consumption during pregnancy. During infancy and particularly during neonatal period, differential diagnosis is difficult. This case is represented by an Italian neonate boy small for gestational age, born by caesarean section at a gestational age of 37 weeks + 6 days by neglect and single-parent pregnancy. On physical examination, he presented particular facial features: microcephaly, epicanthal folds, flat midface, low nasal bridge, indistinct philtrum, and thin upper lip; moreover, examination revealed a macro-penis and recurvation without evidence of glans. Echocardiogram showed an inter-ventricular defect of medium-muscular type and brain magnetic resonance imaging showed asymmetry of the cerebral hemispheres with hypoplasia of the left cerebral hemisphere, dilatation of the left ventricle, cerebrospinal fluid cavity, and porencephaly. We investigated the ethylglucuronide (EtG) concentration in the neonate's hair by liquid chromatography-tandem mass spectrometry and we detected EtG in the infant's hair (normal value, 30 pg/mg), demonstrating prenatal alcohol exposure. In this neonate, EtG measure in hairs permitted the diagnosis of FASD, so allowing to exclude genetic diseases associated with similar clinical findings. After this result the mother admitted that she drunk alcohol during pregnancy (she declared 3 glasses of wine every day). At the age of 6 months, the child showed a moderate neurodevelopmental delay. This case shows that FAD should be considered in neonates with rare neurological diseases as porencephaly. In neonates and infants born to a mother who did not report alcohol use, EtG measure in hairs can significantly improve diagnosis of FASD, so allowing to exclude genetic diseases associated with similar clinical findings.
Identifiants
pubmed: 32756128
doi: 10.1097/MD.0000000000021384
pii: 00005792-202007310-00058
pmc: PMC7402805
doi:
Substances chimiques
Glucuronates
0
ethyl glucuronide
17685-04-0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e21384Références
Wilhoit LF, Scott DA, Simecka BA. Fetal alcohol spectrum disorders: characteristics, complications, and treatment. Community Ment Health J 2017;53:711–8.
Lange S, Probst C, Gmel G, et al. Global prevalence of fetal alcohol spectrum disorder among children and youth: a systematic review and meta-analysis. JAMA Pediatr 2017;171:948–56.
May PA, Baete A, Russo J, et al. Prevalence and characteristics of fetal alcohol spectrum disorders. Pediatrics 2014;134:855–66.
Chasnoff IJ, Wells AM, King L. Misdiagnosis and missed diagnoses in foster and adopted children with prenatal alcohol exposure. Pediatrics 2015;135:264–70.
Hartley M, Tomlinson M, Greco E, et al. Depressed mood in pregnancy: prevalence and correlates in two Cape Town peri-urban settlements. Reprod Health 2011;8:9.
World health Organization. Global status report on alcohol and health 2018. Available from https://apps.who.int/iris/bitstream/handle/10665/274603/9789241565639-eng.pdf?ua=1 Accessed May 22, 2019.
Streissguth AP, Bookstein FL, Barr HM, et al. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J Dev Behav Pediatr 2004;25:228–38.
Riley EP, Infante MA, Warren KR. Fetal alcohol spectrum disorders: an overview. Neuropsychol Rev 2011;21:73–80.
Morini L, Politi L, Groppi A, et al. Determination of ethyl glucuronide in hair samples by liquid chromatography/electrospray tandem mass spectrometry. J Mass Spectrom 2006;41:34–42.
Petrenko CL, Alto ME. Interventions in fetal alcohol spectrum disorders: an international perspective. Eur J Med Genet 2017;60:79–91.
Hoyme HE, Kalberg WO, Elliott AJ, et al. Updated clinical guidelines for diagnosing fetal alcohol spectrum disorders. Pediatrics 2016;138pii: e20154256.
pii: e20154256
Denny L, Coles S, Blitz R. Fetal alcohol syndrome and fetal alcohol spectrum disorders. Am Fam Physician 2017;96:515–22.
Nau S, McCourt EA, Maloney JA, et al. COL4A1 mutations in two infants with congenital cataracts and porencephaly: an ophthalmologic perspective. J AAPOS 2019;23:246–8.
Park HJ, Lee SH, Park HJ, et al. A porencephalic cyst formation in a 6-year-old female with a functioning ventriculoperitoneal shunt: a case-based review. Childs Nerv Syst 2018;34:611–6.
Biondi A, Freni F, Carelli C, et al. Ethyl glucuronide hair testing: a review. Forensic Sci Int 2019;300:106–19.